Whole Genome Sequencing for AML/MDS Risk Stratification
Two clinical trials for AML or MDS are open and enrolling at Siteman Cancer Center and Washington University School of Medicine in St. Louis.
Stay updated with breaking news from Meagan Jacoby. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two clinical trials for AML or MDS are open and enrolling at Siteman Cancer Center and Washington University School of Medicine in St. Louis.
A new test for two blood cancers — developed by a team at Washington University School of Medicine in St. Louis — is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Service
A new test for two blood cancers – developed by a team at Washington University School of Medicine in St. Louis – is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services.